Philips Debuts Fully Integrated Suite of Enhanced Patient Monitoring Solutions in U.S. Market

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the launch of its next-generation Patient Monitoring solution in the U.S. The enterprise-wide system consists of bedside, transport, mobile and central station monitoring technology backed by a new approach to consulting, training, service and customer support, including a full range of product support and expert services. The latest offering features the IntelliVue X3, a transport monitor with intuitive smart-phone-style operation released in 2017. By harmonizing monitoring system updates and improved service agreements, the solution is designed to help clinicians improve patient care, drive clinical performance and assist health systems in lowering costs.

When patients are admitted to the hospital, they are frequently transferred between departments, which can make it difficult for healthcare professionals to obtain complete data from monitoring systems that operate independently of one another. Incomplete data not only limits clinicians’ view into the patient’s condition, but can put a patient’s safety at risk. In a recent Philips-sponsored study, results revealed patient safety is still a top concern for physician and nurse leaders in the U.S. The results showed data is playing an increasingly important role in patient safety, with 74 percent of physician and nurse leaders saying they believe lack of patient data during in-hospital transport is a risk to patients.

"The healthcare industry is making strides to address clinician pain points, but issues such as lack of complete patient data and exhaustive alarm fatigue still remain," said Felix Baader, Business Leader, Monitoring & Analytics at Philips. "While challenges persist, there is an opportunity to improve and address the barriers that clinicians are currently facing with technology. We are aiming to provide clinicians with smarter alarms and seamless solutions to lower the chances of preventable adverse events, while helping them to improve patient care."

The IntelliVue X3 is a highly portable, dual-purpose monitor with intuitive smart-phone-style operation. With this monitor, there is no need for caregivers to change patient cables during transport or at bedside, allowing them to spend less time dealing with equipment and more time caring for the patient. With alarm fatigue a top concern for healthcare professionals, the Patient Monitoring solution also includes IntelliVue bedside monitors with Alarm Advisor, a tool that tracks how clinicians respond to alarms and alerts them when set thresholds may be too sensitive.

As a comprehensive system, the Patient Monitoring solution captures a steady stream of detailed patient data from monitors and medical devices, and feeds it securely to the hospital's EMR for virtually gap-free patient records from admission to discharge, even during transport. The integrated solution fits securely into health systems' existing IT environment, delivering vital signs, waveforms and alarms directly to caregivers. By incorporating these clinical decision support tools and advanced algorithms, caregivers have better visibility into a patient's changing condition. All Philips bedside, transport, and mobile monitors share the same look, feel, and interface for consistency and to reduce complexity, accelerate care, making it easier for clinicians to provide the best quality care throughout patients' transports around the hospital.

The Patient Monitoring solution is available in the U.S. The newest offering in the solution, IntelliVue X3, has recently received 510(k) clearance in the U.S.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 73,000 employees with sales and services in more than 100 countries.

Most Popular Now

Health Fabric and Sandwell Council Secur…

Digital health company Health Fabric is preparing to work with Sandwell Council after learning that it has secured support from The Healthy Ageing Challenge. The company will work with public health...

Philips Highlights AI-Powered Precision …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, showcases its award-winning AI-powered systems and solutions debuting at the European Congress of Radiology (ECR, July 13-17, Vienna...

Could a Computer Diagnose Alzheimer's Di…

It takes a lot of time - and money - to diagnose Alzheimer's disease. After running lengthy in-person neuropsychological exams, clinicians have to transcribe, review, and analyze every response in...

Siemens Healthineers Accelerates and Imp…

Siemens Healthineers presents functionalities powered by Artificial Intelligence (AI) that accelerate and improve Magnetic Resonance Imaging (MRI). The quality of MR imaging is defined by the trade-off between scan time...

Building the Right Foundations to Delive…

Opinion Article by Gary Birks, Gary Birks, General Manager, UK and Ireland, Orion Health. The latest strategy for health and care IT looks to build on what has been achieved over...

Using Technology to Support Primary Care

Opinion Article by Paul Bensley, Managing Director of Primary Care Cloud Telephony Specialist X-on. It is good to see the publication of this strategy [A plan for digital health and social...

A Machine Learning Model to Predict Immu…

Immunotherapy is a new cancer treatment that activates the body's immune system to fight against cancer cells without using chemotherapy or radiotherapy. It has fewer side effects than conventional anticancer...

Virtual Reality App Trial Shown to Reduc…

Results from a University of Otago, Christchurch trial suggest fresh hope for the estimated one-in-twelve people worldwide suffering from a fear of flying, needles, heights, spiders and dogs. The trial, led...

Two Leading CIOs Join the Highland Marke…

Two of the NHS' most dynamic chief information officers have joined Highland Marketing’s advisory board of NHS IT professionals and health tech industry experts. Ian Hogan, a CIO at the Northern...

Teaching AI to Ask Clinical Questions

Physicians often query a patient's electronic health record for information that helps them make treatment decisions, but the cumbersome nature of these records hampers the process. Research has shown that...

AI Analyses Neuron Changes to Detect whe…

A research group from Nagoya University in Japan has developed an artificial intelligence (AI) for analyzing cell images that uses machine learning to predict the therapeutic effect of drugs. Called...

MIT Engineers Develop Stickers that can …

Ultrasound imaging is a safe and noninvasive window into the body’s workings, providing clinicians with live images of a patient’s internal organs. To capture these images, trained technicians manipulate ultrasound...